1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34872
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMackintosh, John A-
dc.contributor.authorKeir, Gregory-
dc.contributor.authorTroy, Lauren K-
dc.contributor.authorHolland, Anne E-
dc.contributor.authorGrainge, Christopher-
dc.contributor.authorChambers, Daniel C-
dc.contributor.authorSandford, Debra-
dc.contributor.authorJo, Helen E-
dc.contributor.authorGlaspole, Ian-
dc.contributor.authorWilsher, Margaret-
dc.contributor.authorGoh, Nicole S L-
dc.contributor.authorReynolds, Paul N-
dc.contributor.authorChapman, Sally-
dc.contributor.authorMutsaers, Steven E-
dc.contributor.authorde Boer, Sally-
dc.contributor.authorWebster, Susanne-
dc.contributor.authorMoodley, Yuben-
dc.contributor.authorCorte, Tamera J-
dc.date2024-
dc.date.accessioned2024-01-19T05:25:04Z-
dc.date.available2024-01-19T05:25:04Z-
dc.date.issued2024-02-
dc.identifier.citationRespirology (Carlton, Vic.) 2024-02; 29(2)en_US
dc.identifier.issn1440-1843-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34872-
dc.description.abstractIdiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA) published a position statement on the treatment of IPF. Since that time, subsidized anti-fibrotic therapy in the form of pirfenidone and nintedanib is now available in both Australia and New Zealand. More recently, evidence has been published in support of nintedanib for non-IPF progressive pulmonary fibrosis (PPF). Additionally, there have been numerous publications relating to the non-pharmacologic management of IPF and PPF. This 2023 update to the position statement for treatment of IPF summarizes developments since 2017 and reaffirms the importance of a multi-faceted approach to the management of IPF and progressive pulmonary fibrosis.en_US
dc.language.isoeng-
dc.subjectidiopathic pulmonary fibrosisen_US
dc.subjectinterstitial lung diseaseen_US
dc.subjectprogressive pulmonary fibrosisen_US
dc.subjectpulmonary fibrosisen_US
dc.subjecttreatmenten_US
dc.titleTreatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleRespirology (Carlton, Vic.)en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.;Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.;University of Sydney, Sydney, New South Wales, Australia.en_US
dc.identifier.affiliationCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.;Department of Physiotherapy, The Alfred Hospital, Melbourne, Victoria, Australia.;Department of Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.;Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.en_US
dc.identifier.affiliationCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.;Department of Thoracic Medicine, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.;University of Adelaide, Adelaide, South Australia, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.;University of Sydney, Sydney, New South Wales, Australia.en_US
dc.identifier.affiliationCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.;Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Te Toka Tumai Auckland, Auckland, New Zealand.en_US
dc.identifier.affiliationRespiratory and Sleep Medicineen_US
dc.identifier.affiliationCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.;Department of Thoracic Medicine, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.;University of Adelaide, Adelaide, South Australia, Australia.en_US
dc.identifier.affiliationInstitute for Respiratory Health, University of Western Australia, Nedlands, Western Australia, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Te Toka Tumai Auckland, Auckland, New Zealand.en_US
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.en_US
dc.identifier.affiliationCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.;Institute for Respiratory Health, University of Western Australia, Nedlands, Western Australia, Australia.;Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.en_US
dc.identifier.affiliation;Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.;University of Sydney, Sydney, New South Wales, Australia.en_US
dc.identifier.doi10.1111/resp.14656en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-5254-4144en_US
dc.identifier.orcid0000-0001-9979-8726en_US
dc.identifier.orcid0000-0003-2061-845Xen_US
dc.identifier.orcid0000-0002-6565-9928en_US
dc.identifier.orcid0000-0002-9553-5870en_US
dc.identifier.orcid0000-0002-5118-2890en_US
dc.identifier.orcid0000-0003-2046-8957en_US
dc.identifier.orcid0000-0003-2065-4346en_US
dc.identifier.orcid0000-0002-2273-1774en_US
dc.identifier.orcid0000-0002-0777-1196en_US
dc.identifier.orcid0000-0002-7096-9365en_US
dc.identifier.pubmedid38211978-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptPhysiotherapy-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

48
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.